Charming Medical Limited (MCTA)

Charming Medical Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Net Income	0.66	1.2	0.82	-0.34
Depreciation & Amortization	0.23	0.26	0.39	0.21
Other Adjustments	0.06	0.12	0.03	0.06
Change in Receivables	0.25	-0.04	-0.16	-0.15
Changes in Inventories	-0.01	0	0.04	-0.06
Changes in Accrued Expenses	-0.13	-0.2	0.21	0.18
Changes in Income Taxes Payable	0.05	0.1	0.12	-
Changes in Unearned Revenue	-0.49	-1.06	-1.11	2.73
Changes in Other Operating Activities	0.05	0.04	-0.04	-0.2
Operating Cash Flow	0.68	0.43	0.3	2.43
Operating Cash Flow Growth	266.71%	44.16%	-87.86%	-
Capital Expenditures	-0.28	-0.29	-0.21	-0.61
Sale of Property, Plant & Equipment	0.03	-	-	-
Purchases of Investments	-	-1.94	-	-
Proceeds from Sale of Investments	1.04	-	-	-
Investing Cash Flow	-1.15	-2.23	-0.21	-0.61
Long-Term Debt Issued	0.12	0.21	0.04	-
Long-Term Debt Repaid	-0.28	-0.16	-0.15	-0.18
Net Long-Term Debt Issued (Repaid)	-0.16	0.05	-0.12	-0.18
Issuance of Common Stock	0.38	-	-	-
Net Common Stock Issued (Repurchased)	0.38	-	-	-
Other Financing Activities	-0.68	0.47	0.22	-1.25
Financing Cash Flow	-0.46	0.52	0.1	-1.43
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.01	-0	-0.01	0.01
Net Cash Flow	-0.92	-1.28	0.18	0.4
Free Cash Flow	0.4	0.14	0.08	1.83
Free Cash Flow Growth	190.01%	63.10%	-95.36%	-
FCF Margin	7.40%	2.22%	1.41%	51.76%
Free Cash Flow Per Share	0.03	0.01	0.01	0.12
Levered Free Cash Flow	-0.07	0.11	0.06	1.77
Unlevered Free Cash Flow	-0.09	0.02	0.23	1.84

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q